Table 2.
Adverse effects (>grade 2)
| CHOP n=40 (%) | THP-COP n=40 (%) | |
|---|---|---|
| Hematological toxicity | ||
| Anemia | 2 (5.0) | 1 (2.5) |
| Neutropenia | 12 (30.0) | 13 (32.5) |
| Thrombocytopenia | 1 (2.5) | 2 (5.0) |
| Non-hematological toxicity | ||
| Nausea/vomiting | 2 (5.0) | 1 (2.5) |
| Stomatitis | 2 (5.0) | 2 (5.0) |
| Diarrhea | 0 | 0 |
| Constipation | 1 (2.5) | 1 (2.5) |
| Liver dysfunction | 1 (2.5) | 2 (5.0) |
| Renal dysfunction | 1 (2.5) | 0 |
| Hematuria | 1 (2.5) | 0 |
| Arrythmia | 1 (5.5) | 0 |
| Heart failure | 1 | 0 |
| Respiratory failure | 0 | 1 (2.5) |
| Neuropathy | 1 (2.5) | 2 (5.0) |
| Infection | 1 (2.5) | 2 (5.0) |